Table 2.
The effect of ivermectin and albendazole sulfoxide on P. falciparum sporogony in An. gambiae treatments
| Stage (DPI) | Control | IVM | IVM and ALB SOx |
|---|---|---|---|
| Oocyst (7) | |||
| Prevalence mean (SEM) | 73.96 (4.48) | 57.14 (4.54) | 60.34 (4.54) |
| χ2 value | Reference | 8.4717 | 4.3705 |
| P value | Reference | 0.0004* | 0.0413* |
| N | Reference | 215 | 212 |
| Intensity mean (SEM) | 14.11 (2.435) | 16.38 (2.255) | 12.67 (1.371) |
| P value | Reference | 0.0708 | 0.0641 |
| N | Reference | 134 | 141 |
| Sporozoite (14) | |||
| Prevalence mean (SEM) | 76.84 (4.33) | 50.0 (5.21) | 53.61 (5.06) |
| χ2 value | Reference | 14.5523 | 11.4309 |
| P value | Reference | < 0.0001* | < 0.0001* |
| N | Reference | 187 | 192 |
ALB Sox = albendazole sulfoxide; DPI = days post-infection; IVM = ivermectin.
*
Results are significant.